Volume 54 | Number 6 | December 2019

Abstract List

Leah L. Zullig PhD MPH, Shelley A. Jazowski MPH, Tracy Y. Wang MD MHS MSc, Anne Hellkamp MS, Daniel Wojdyla MS, Laine Thomas PhD, Lisa Egbuonu‐Davis MD MPH MBA, Anne Beal MD MPH, Hayden B. Bosworth PhD


To compare predictive analytic approaches to characterize medication nonadherence and determine under which circumstances each method may be best applied.

Data Sources/Study Setting

Medicare Parts A, B, and D claims from 2007 to 2013.

Study Design

We evaluated three statistical techniques to predict statin adherence (proportion of days covered [PDC ≥ 80 percent]) in the year following discharge: standard logistic regression with backward selection of covariates, least absolute shrinkage and selection operator (LASSO), and random forest. We used the C‐index to assess model discrimination and decile plots comparing predicted values to observed event rates to evaluate model performance.

Data Extraction

We identified 11 969 beneficiaries with an acute myocardial infarction (MI)‐related admission from 2007 to 2012, who filled a statin prescription at, or shortly after, discharge.

Principal Findings

In all models, prior statin use was the most important predictor of future adherence (OR = 3.65, 95% CI: 3.34‐3.98; OR = 3.55). Although the LASSO regression model selected nearly 90 percent of all candidate predictors, all three analytic approaches had moderate discrimination (C‐index ranging from 0.664 to 0.673).


Although none of the models emerged as clearly superior, predictive analytics could proactively determine which patients are at risk of nonadherence, thus allowing for timely engagement in adherence‐improving interventions.